ProCE Banner Activity

Which Patients With Hepatitis B Should We Be Treating?

Podcast Episodes

Listen as Ira M. Jacobson, MD; Paul Y. Kwo, MD; and Tatyana Kushner, MD, MSCE, discuss guideline recommendations for HBV treatment indications, recent data describing the relationship between viral suppression and HBV DNA integration, and more expansive indications for HBV treatment based on virologic considerations.

Released: November 29, 2023

Share

Faculty

Ira Jacobson

Ira Jacobson, MD

Professor of Medicine
Director of Hepatology
NYU Langone Health
New York, New York

Tatyana Kushner

Tatyana Kushner, MD, MSCE

Associate Professor
Division of Liver Diseases
Icahn School of Medicine at Mount Sinai
New York, New York

Paul Y. Kwo

Paul Y. Kwo, MD

Professor of Medicine
Director of Hepatology
Stanford University School of Medicine
Palo Alto, California

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Presented for attendees of The Liver Meeting® 2023. This event/function is provided by Clinical Care Options, LLC and supported by GlaxoSmithKline. This is not an official event/function of the American Association for the Study of Liver Diseases.

Per AASLD - The statements must be used together, must be adjacent to one another, and must appear in the same type size and treatment. It is not acceptable to use “in conjunction with The Liver Meeting® 2023” or “during The Liver Meeting® 2023” or reference The Liver Meeting® and/or The Liver Meeting Digital Experience™.

GlaxoSmithKline

Disclosure

Primary Author

Ira Jacobson, MD

Professor of Medicine
Director of Hepatology
NYU Langone Health
New York, New York

Ira Jacobson, MD: researcher: Assembly Biosciences, Bristol-Myers Squibb, Eiger, Enanta, Genkyotex, Gilead, GlaxoSmithKline, Intercept, Janssen, Lilly, Merck, Mirum, Novo Nordisk; consultant/advisor: Aligos, Arbutus, Arrowhead, Galapagos, Gilead, GlaxoSmithKline, Intercept, Janssen, Merck, Roche, Takeda; data monitoring committee: Aligos, Altimmune, GlaxoSmithKline, Takeda.

Tatyana Kushner, MD, MSCE

Associate Professor
Division of Liver Diseases
Icahn School of Medicine at Mount Sinai
New York, New York

Tatyana Kushner, MD, MSCE: consultant/advisor/speaker: AbbVie, Eiger, Gilead, GlaxoSmithKline; researcher: Gilead.